P3.12D.01 A Phase Ib Study of Osimertinib and Tegavivint as First-Line Therapy in Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Regan Memmott; Jinesh Gheeya; Lai Wei; M. Phelps; Wenxian Yang; D. Stenehjem; Stephen Horrigan; Andrew W. Duncan; D. Uribe; Giovanni Amato; G. Otterson; Jacob M. Kaufman; Ahlam A. Alahmadi; Carolyn J. Presley; Dwight H. Owen; David P. Carbone

doi:10.1016/j.jtho.2024.09.623

P3.12D.01 A Phase Ib Study of Osimertinib and Tegavivint as First-Line Therapy in Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Regan Memmott(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jinesh Gheeya(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Lai Wei(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), M. Phelps(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Wenxian Yang(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), D. Stenehjem(University of Minnesota), Stephen Horrigan(Esperion Therapeutics (United States)), Andrew W. Duncan(Esperion Therapeutics (United States)), D. Uribe(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Giovanni Amato(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), G. Otterson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jacob M. Kaufman(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ahlam A. Alahmadi(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Carolyn J. Presley(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Dwight H. Owen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), David P. Carbone(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)

Journal of Thoracic Oncology

October 1, 2024

10.1016/j.jtho.2024.09.623

Cited by 1Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis